Panagiotis Tsourapas - May 9, 2024 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
May 9, 2024
Transactions value $
-$262,374
Form type
4
Date filed
5/10/2024, 04:16 PM
Previous filing
Feb 20, 2024
Next filing
Aug 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $867K +12K +234.47% $72.29 17.1K May 9, 2024 Direct F1
transaction CL Common Stock Sale -$1.13M -12K -70.1% $94.15 5.12K May 9, 2024 Direct F2, F3
holding CL Common Stock 4.35K May 9, 2024 By Issuer's 401(k) Plan Trustee
holding CL Common Stock 69.2K May 9, 2024 By Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -12K -17.97% $0.00 54.8K May 9, 2024 Common Stock 12K $72.29 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.15 to $94.1703, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This amount includes 9,922 shares that were previously reported as directly beneficially owned.
F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date.